Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (81-90 of 271) with videos related to

Pageof 28
Sort By:
International Journal of Cancer|August 24, 2012
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent yearsLaura Cortesi, Luigi Marcheselli, Valentina Guarneri, et al.
Journal of Breast Cancer|October 11, 2016
Increased Incidence of Breast Cancer in Postmenopausal Women with High Body Mass Index at the Modena Screening ProgramFederica Sebastiani, Laura Cortesi, Milena Sant, et al.
Haematologica|August 14, 2008
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort studyStefano Sacchi, Luigi Marcheselli, Alessia Bari, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphomaPaolo G Gobbi, Vittorio Rosti, Francesco Valentino, et al.
Cancer Causes & Control : CCC|March 20, 2002
Stage-specific incidence of breast cancer before the beginning of organized screening programs in ItalyEva Buiatti, Alessandro Barchielli, Simone Bartolacci, et al.
Oncology|August 30, 2017
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort StudyLaura Cortesi, Elisabetta De Matteis, Angela Toss, et al.
Cancer Biology & Medicine|March 12, 2021
<i>BRCA</i> mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigreesLaura Cortesi, Federica Domati, Annalisa Guida, et al.
Cancer|December 11, 2012
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemiaStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Leukemia Research|March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysisStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Electrophoresis|July 6, 2011
Protein expression patterns associated with advanced stage ovarian cancerLaura Cortesi, Elena Rossi, Lara Della Casa, et al.
Pageof 28

Showing results (81-90 of 271) with videos related to

Sort By:
Pageof 28
International Journal of Cancer|August 24, 2012
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent yearsLaura Cortesi, Luigi Marcheselli, Valentina Guarneri, et al.
Journal of Breast Cancer|October 11, 2016
Increased Incidence of Breast Cancer in Postmenopausal Women with High Body Mass Index at the Modena Screening ProgramFederica Sebastiani, Laura Cortesi, Milena Sant, et al.
Haematologica|August 14, 2008
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort studyStefano Sacchi, Luigi Marcheselli, Alessia Bari, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphomaPaolo G Gobbi, Vittorio Rosti, Francesco Valentino, et al.
Cancer Causes & Control : CCC|March 20, 2002
Stage-specific incidence of breast cancer before the beginning of organized screening programs in ItalyEva Buiatti, Alessandro Barchielli, Simone Bartolacci, et al.
Oncology|August 30, 2017
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort StudyLaura Cortesi, Elisabetta De Matteis, Angela Toss, et al.
Cancer Biology & Medicine|March 12, 2021
<i>BRCA</i> mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigreesLaura Cortesi, Federica Domati, Annalisa Guida, et al.
Cancer|December 11, 2012
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemiaStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Leukemia Research|March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysisStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Electrophoresis|July 6, 2011
Protein expression patterns associated with advanced stage ovarian cancerLaura Cortesi, Elena Rossi, Lara Della Casa, et al.
Pageof 28